Skip to main content

Eating Disorders

The US Food and Drug Administration (FDA) has accepted a New Drug Application for dasotraline for the treatment of patients with moderate-to-severe binge eating disorder, Sunovion Pharmaceuticals Inc. recently announced.
ORLANDO, Fla.—In adults with binge-eating disorder, dasotraline was linked with significant gains in behavioral and psychological outcomes, compared with placebo, researchers reported at Psych Congress 2018.
A recent meta-analysis found a correlation between the proinflammatory cytokines tumor necrosis factor (TNF)-α and interleukin 6 (IL-6) and which eating disorder?
NEW YORK CITY—The extended-release form of phentermine/topiramate is safe and effective for reducing binge eating, suggests a small study presented at the American Psychiatric Association’s annual meeting.
Mindfulness interventions may be effective in interrupting cravings for food, cigarettes, and alcohol by occupying short-term memory, according to a new review.
Back to Top